糖尿病黄斑水肿-话题@MedSci

#糖尿病黄斑水肿#

10篇内容 | 1501人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2166294, encodeId=ca772166294aa, content=<a href='/topic/show?id=371de681325' target=_blank style='color:#2F92EE;'>#糖尿病黄斑水肿#</a> , objectTitle=糖尿病黄斑水肿严重程度分级标准, objectType=scale, longId=3586, objectId=3586, topicUrl=null, isHasObj=0, objectCover=https://static.medsci.cn/public-image/ms-image/c4014af0-a4f3-11ec-a1b8-6123b3ff61ea_企业微信截图_16472234662720.png, objectUrl=https://m.medsci.cn//scale/show.do?id=571f3586a3, replyNumber=0, likeNumber=49, createdTime=2023-11-02, rootId=0, userName=litao2022, userId=1ff65466529, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=3586, moduleTitle=糖尿病黄斑水肿严重程度分级标准, moduleType=scale, hrefUrl=https://m.medsci.cn/scale/show.do?id=571f3586a3)], followStatus=false, userIsMember=true, type=1, lengthMark=0), GetTopicListResponse(id=2165230, encodeId=467a21652305b, content=<a href='/topic/show?id=077112e9237' target=_blank style='color:#2F92EE;'>#NICE#</a> <a href='/topic/show?id=b0da98838c7' target=_blank style='color:#2F92EE;'>#雷珠单抗#</a>治疗<a href='/topic/show?id=371de681325' target=_blank style='color:#2F92EE;'>#糖尿病黄斑水肿#</a>, objectTitle=2023 NICE 技术鉴定指南：雷珠单抗治疗糖尿病黄斑水肿, objectType=guider, longId=26795, objectId=8e46f1c003a156e0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/guideline/show_article.do?id=8e46f1c003a156e0, replyNumber=0, likeNumber=97, createdTime=2023-10-27, rootId=0, userName=litao2022, userId=1ff65466529, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=8e46f1c003a156e0, moduleTitle=2023 NICE 技术鉴定指南：雷珠单抗治疗糖尿病黄斑水肿, moduleType=guider, hrefUrl=https://www.medsci.cn/guideline/show_article.do?id=8e46f1c003a156e0)], followStatus=false, userIsMember=true, type=1, lengthMark=0), GetTopicListResponse(id=2162024, encodeId=c41b2162024d2, content=<a href='/topic/show?id=4f77e665253' target=_blank style='color:#2F92EE;'>#糖尿病#</a><a href='/topic/show?id=371de681325' target=_blank style='color:#2F92EE;'>#糖尿病黄斑水肿#</a><a href='/topic/show?id=bb09e67752b' target=_blank style='color:#2F92EE;'>#糖尿病视网膜病变#</a>, objectTitle=糖尿病黄斑水肿患者行醋酸氟轻松治疗规范：2023年专家共识解读, objectType=guider, longId=26352, objectId=70da71c0033e13c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/guideline/show_article.do?id=70da71c0033e13c5, replyNumber=0, likeNumber=104, createdTime=2023-10-10, rootId=0, userName=Gym璨烨, userId=edd01701426, projectId=1, avatar=null, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=70da71c0033e13c5, moduleTitle=糖尿病黄斑水肿患者行醋酸氟轻松治疗规范：2023年专家共识解读, moduleType=guider, hrefUrl=https://www.medsci.cn/guideline/show_article.do?id=70da71c0033e13c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1518205, encodeId=d1741518205e7, content=<a href='/topic/show?id=371de681325' target=_blank style='color:#2F92EE;'>#糖尿病黄斑水肿#</a>, objectTitle=诺华宣布FDA接受Beovu治疗糖尿病黄斑水肿患者的申请, objectType=article, longId=218746, objectId=47b2218e46d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=47b2218e46d3, replyNumber=0, likeNumber=77, createdTime=2021-10-18, rootId=0, userName=循证小兵, userId=b88311125888, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=47b2218e46d3, moduleTitle=诺华宣布FDA接受Beovu治疗糖尿病黄斑水肿患者的申请, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=47b2218e46d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1518204, encodeId=ba0c15182046b, content=<a href='/topic/show?id=371de681325' target=_blank style='color:#2F92EE;'>#糖尿病黄斑水肿#</a>, objectTitle=ASRS 2020：OPT-302治疗糖尿病黄斑水肿取得积极进展, objectType=article, longId=198164, objectId=1b5819816444, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1b5819816444, replyNumber=0, likeNumber=96, createdTime=2020-07-29, rootId=0, userName=循证小兵, userId=b88311125888, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1b5819816444, moduleTitle=ASRS 2020：OPT-302治疗糖尿病黄斑水肿取得积极进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1b5819816444)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1518203, encodeId=64d11518203c4, content=<a href='/topic/show?id=371de681325' target=_blank style='color:#2F92EE;'>#糖尿病黄斑水肿#</a>, objectTitle=Ophthalmologica：具有浆液性视网膜脱离的糖尿病黄斑水肿的新型生物标志物-血清几丁质酶-3样蛋白1, objectType=article, longId=147859, objectId=569314e859ad, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=569314e859ad, replyNumber=0, likeNumber=77, createdTime=2018-09-01, rootId=0, userName=循证小兵, userId=b88311125888, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=569314e859ad, moduleTitle=Ophthalmologica：具有浆液性视网膜脱离的糖尿病黄斑水肿的新型生物标志物-血清几丁质酶-3样蛋白1, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=569314e859ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1518202, encodeId=402f15182029d, content=<a href='/topic/show?id=371de681325' target=_blank style='color:#2F92EE;'>#糖尿病黄斑水肿#</a>, objectTitle=Ophthalmologica：糖尿病黄斑水肿患者的眼房水中可溶性血管内皮生长因子受体(sVEGFR)和炎症因子的水平显著高于非糖尿病人！, objectType=article, longId=100470, objectId=3fb01004e068, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3fb01004e068, replyNumber=0, likeNumber=83, createdTime=2017-06-03, rootId=0, userName=循证小兵, userId=b88311125888, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3fb01004e068, moduleTitle=Ophthalmologica：糖尿病黄斑水肿患者的眼房水中可溶性血管内皮生长因子受体(sVEGFR)和炎症因子的水平显著高于非糖尿病人！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3fb01004e068)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1518201, encodeId=17fe1518201d4, content=<a href='/topic/show?id=371de681325' target=_blank style='color:#2F92EE;'>#糖尿病黄斑水肿#</a>, objectTitle=NGGZ：哌加他尼钠针对糖尿病黄斑水肿患者在日本进行III期临床研究, objectType=article, longId=43449, objectId=ff854344901, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ff854344901, replyNumber=0, likeNumber=76, createdTime=2014-12-01, rootId=0, userName=循证小兵, userId=b88311125888, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ff854344901, moduleTitle=NGGZ：哌加他尼钠针对糖尿病黄斑水肿患者在日本进行III期临床研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ff854344901)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1518200, encodeId=c8a7151820073, content=<a href='/topic/show?id=371de681325' target=_blank style='color:#2F92EE;'>#糖尿病黄斑水肿#</a>, objectTitle=BMJ:贝伐珠单抗和雷珠单抗治疗糖尿病黄斑水肿无显著性差异, objectType=article, longId=9014, objectId=b7e790149f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b7e790149f, replyNumber=0, likeNumber=70, createdTime=2012-08-17, rootId=0, userName=循证小兵, userId=b88311125888, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b7e790149f, moduleTitle=BMJ:贝伐珠单抗和雷珠单抗治疗糖尿病黄斑水肿无显著性差异, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b7e790149f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1518199, encodeId=c6e2151819915, content=<a href='/topic/show?id=371de681325' target=_blank style='color:#2F92EE;'>#糖尿病黄斑水肿#</a>, objectTitle=FDA推荐雷珠单抗治疗糖尿病黄斑水肿, objectType=article, longId=8616, objectId=88d586166c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=88d586166c, replyNumber=0, likeNumber=80, createdTime=2012-08-08, rootId=0, userName=循证小兵, userId=b88311125888, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=88d586166c, moduleTitle=FDA推荐雷珠单抗治疗糖尿病黄斑水肿, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=88d586166c)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

糖尿病黄斑水肿

2020-05-29

(审核中...)

前往app查看评论内容

#糖尿病黄斑水肿#

糖尿病黄斑水肿严重程度分级标准

2023-11-02发表于上海

(审核中...)

前往app查看评论内容

#NICE# #雷珠单抗#治疗#糖尿病黄斑水肿#

2023 NICE 技术鉴定指南：雷珠单抗治疗糖尿病黄斑水肿

2023-10-27发表于上海

Gym璨烨 (审核中...)

前往app查看评论内容

#糖尿病##糖尿病黄斑水肿##糖尿病视网膜病变#

糖尿病黄斑水肿患者行醋酸氟轻松治疗规范：2023年专家共识解读

2023-10-10发表于上海

循证小兵 (审核中...)

前往app查看评论内容

#糖尿病黄斑水肿#

诺华宣布FDA接受Beovu治疗糖尿病黄斑水肿患者的申请

2021-10-18

循证小兵 (审核中...)

前往app查看评论内容

#糖尿病黄斑水肿#

ASRS 2020：OPT-302治疗糖尿病黄斑水肿取得积极进展

2020-07-29

循证小兵 (审核中...)

前往app查看评论内容

#糖尿病黄斑水肿#

Ophthalmologica：具有浆液性视网膜脱离的糖尿病黄斑水肿的新型生物标志物-血清几丁质酶-3样蛋白1

2018-09-01

循证小兵 (审核中...)

前往app查看评论内容

#糖尿病黄斑水肿#

Ophthalmologica：糖尿病黄斑水肿患者的眼房水中可溶性血管内皮生长因子受体(sVEGFR)和炎症因子的水平显著高于非糖尿病人！

2017-06-03

循证小兵 (审核中...)

前往app查看评论内容

#糖尿病黄斑水肿#

NGGZ：哌加他尼钠针对糖尿病黄斑水肿患者在日本进行III期临床研究

2014-12-01

循证小兵 (审核中...)

前往app查看评论内容

#糖尿病黄斑水肿#

BMJ:贝伐珠单抗和雷珠单抗治疗糖尿病黄斑水肿无显著性差异

2012-08-17

循证小兵 (审核中...)

前往app查看评论内容

#糖尿病黄斑水肿#

FDA推荐雷珠单抗治疗糖尿病黄斑水肿

2012-08-08

科室
- - 订阅+
  - 更多科室
工具
服务